Lv51
1190 积分 2023-03-27 加入
Abstract 48: T cell-specific in vivo transduction with preclinical candidate KLN-1010 generates BCMA directed CAR T cells with potent anti-multiple myeloma activity
2个月前
已关闭
Antigen identification and high-throughput interaction mapping by reprogramming viral entry
2个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
3个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
4个月前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
5个月前
已完结
Engineering CAR-T Cells for Next-Generation Cancer Therapy
5个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
7个月前
已完结
In vivo site-specific engineering to reprogram T cells
7个月前
已完结
Recent advances in therapeutic cancer vaccines
7个月前
已完结